Prevention of descending pneumonia in rats with perflubron-delivered tobramycin

Academic Emergency Medicine

Volumn 10, Issue 10, 2003, Pages 1019-1023

  Dickson, Eric W ^a,b   Doern, Gary V ^b   Trevino, Leo ^c   Mazzoni, Michelle ^c   Heard, Stephen O ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c Alliance Pharmaceutical Corporation   (United States)

Author keywords

Klebsiella; LiquiVent; Pneumonia; Prevention; Rats; Ventilator

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; MICROSPHERE; PERFLUOROOCTYL BROMIDE; TOBRAMYCIN;

ANIMAL; ANIMAL MODEL; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL PNEUMONIA; CONTROLLED STUDY; DISEASE MODEL; DRUG DELIVERY SYSTEM; DRUG EFFECT; ENDOTRACHEAL INTUBATION; ENTEROBACTER INFECTION; GRAM NEGATIVE INFECTION; INFECTION RISK; INTUBATION; KLEBSIELLA PNEUMONIAE; MALE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RAT; RAT STRAIN; SURVIVAL RATE; TREATMENT OUTCOME; VENTILATOR;

EID: 0141780877     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1197/S1069-6563(03)00335-X     Document Type: Article

References (27)

1. Rello J, Diaz E, Roque M, Valles J. Risk factors for developing pneumonia within 48 hours of intubation. Am J Respir Crit Care Med. 1999; 159:1742-6.
2. Rello J, Ollendorf DA, Oster G, et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest. 2002; 122:2115-21.
3. Valles J, Artigas A, Rello J, et al. Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia. Ann Intern Med. 1995; 122:179-86.
4. Smulders K, van der Hoeven H, Weers-Pothoff I, Vanden-broucke-Grauls C. A randomized clinical trial of intermittent subglottic secretion drainage in patients receiving mechanical ventilation. Chest. 2002; 121:858-62.
5. Drakulovic MB, Torres A, Bauer TT, Nicolas JM, Nogue S, Ferrer M. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet. 1999; 354:1851-8.
6. Kollef MH. The role of selective digestive tract decontamination on mortality and respiratory tract infections. A meta-analysis. Chest. 1994; 105:1101-8.
7. Krueger WA, Unertl KE. Selective decontamination of the digestive tract. Curr Opin Crit Care. 2002; 8:139-44.
8. Sirvent JM, Torres A, El-Ebiary M, Castro P, de Batlle J, Bonet A. Protective effect of intravenously administered cefuroxime against nosocomial pneumonia in patients with structural coma. Am J Respir Crit Care Med. 1997; 155:1729-34.
9. Beuret P, Carton MJ, Nourdine K, Kaaki M, Tramoni G, Ducreux JC. Prone position as prevention of lung injury in comatose patients: a prospective, randomized, controlled study. Intensive Care Med. 2002; 28:564-9.
10. Girou E, Schortgen F, Delclaux C, et al. Association of noninvasive ventilation with nosocomial infections and survival in critically ill patients. JAMA. 2000; 284:2361-7.
11. Gentilello L, Thompson DA, Tonnesen AS, et al. Effect of a rotating bed on the incidence of pulmonary complications in critically ill patients. Crit Care Med. 1988; 16:783-6.
12. deBoisblanc BP, Castro M, Everret B, Grender J, Walker CD, Summer WR. Effect of air-supported, continuous, postural oscillation on the risk of early ICU pneumonia in nontraumatic critical illness. Chest. 1993; 103:1543-7.
13. Fink MP, Helsmoortel CM, Stein KL, Lee PC, Cohn SM. The efficacy of an oscillating bed in the prevention of lower respiratory tract infection in critically ill victims of blunt trauma. A prospective study. Chest. 1990; 97:132-7.
14. Carcas AJ, Garcia-Satue JL, Zapater P, Frias-Iniesta J. Tobramycin penetration into epithelial lining fluid of patients with pneumonia. Clin Pharmacol Ther. 1999; 65:245-50.
15. Cole PJ. The role of nebulized antibiotics in treating serious respiratory infections. J Chemother. 2001; 13:354-62.
16. Coates AL, Dinh L, MacNeish CF, et al. Accounting for radioactivity before and after nebulization of tobramycin to insure accuracy of quantification of lung deposition. J Aerosol Med. 2000; 13:169-78.
17. Ricard JD, Lemaire F. Liquid ventilation. Curr Opin Crit Care. 2001; 7:8-14.
18. Dickson EW, Heard SO, Chu B, Fraire A, Brueggemann AB, Doern GV. Partial liquid ventilation with perfluorocarbon in the treatment of rats with lethal pneumococcal pneumonia. Anesthesiology. 1998; 88:218-23.
19. Franz AR, Rohlke W, Franke RP, Ebsen M, Pohlandt F, Hummler HD. Pulmonary administration of perfluorodecaline-gentamicin and perfluorodecaline-vancomycin emulsions. Am J Respir Crit Care Med. 2001; 164:1595-600.
20. Cox CA, Cullen AB, Wolfson MR, Shaffer TH. Intratracheal administration of perfluorochemical-gentamicin suspension: a comparison to intravenous administration in normal and injured lungs. Pediatr Pulmonol. 2001; 32:142-51.
21. Dickson EW, Heard SO, Goodin T, Brueggemann AB, Doern GV. Use of a penicillin containing perfluorocarbon emulsion in the treatment of rats with lethal pneumococcal pneumonia [abstract]. Crit Care Med. 1996; 24:A29.
22. National Institutes of Health. Guide for the use of laboratory animals. Bethesda, MD: NIH, 1996, Vol. 25, no. 28.
23. Dickson EW, Heard SO, Tarara TE, Weers JG, Brueggemann AB, Doern GV. Liquid ventilation with perflubron in the treatment of rats with pneumococcal pneumonia. Crit Care Med. 2002; 30:393-5.
24. Shaffer TH, Wolfson MR, Clark LC Jr. Liquid ventilation. Pediatr Pulmonol. 1992; 14:102-9.
25. Dickson EW, Heard SO, Otto S, Tarara TE, Brun-Buisson C, Doern GV. Efficacy of a novel perfluorocarbon-based intrapulmonary drug delivery system [abstract]. Crit Care Med. 1998; 26:A143.
26. Frimodt-Moller N. How predictive is PK/PD for antibacterial agents? Int J Antimicrob Agents. 2002; 19:333-9.
27. Hirschl RB, Croce M, Gore D, et al. Prospective, randomized, controlled pilot study of partial liquid ventilation in adult acute respiratory distress syndrome. Am J Respir Crit Care Med. 2002; 165:781-7.